NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP
· Real-Time Price · USD
2.26
-0.01 (-0.44%)
At close: Jun 17, 2025, 3:43 PM
-0.44% (1D)
| Bid | 2.26 |
| Market Cap | 8.13M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -2.04M |
| EPS (ttm) | -2.63 |
| PE Ratio (ttm) | -0.86 |
| Forward PE | 0.05 |
| Analyst | n/a |
| Ask | 2.3 |
| Volume | 148,114 |
| Avg. Volume (20D) | 222,401 |
| Open | 2.28 |
| Previous Close | 2.27 |
| Day's Range | 2.26 - 2.36 |
| 52-Week Range | 1.30 - 18.40 |
| Beta | 0.04 |
About NLSP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NLSP
Website n/a
2 months ago
+18.46%
NLS Pharmaceutics shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
+37.43%
NLS Pharmaceutics shares are trading higher after the company announced it will join forces with Kadimastem for diabetes treatment.
